Shanghai Haohai Biological Technology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 6826?
Owner Type	Number of Shares	Ownership Percentage
Institutions	25,210,490	10.9%
General Public	61,186,288	26.6%
Individual Insiders	143,880,004	62.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 72.51% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
46.4%	Jie You	106,848,000	HK$6.4b	-2.14%	no data
3.74%	Guoliang Lou	8,611,661	HK$513.5m	0%	no data
3.69%	Jianying Wu	8,495,717	HK$506.5m	0%	no data
3.65%	Yongtai Hou	8,408,764	HK$501.4m	0%	no data
1.3%	Zhong Ou Fund Management Co., Ltd	2,997,903	HK$178.7m	0%	0.09%
1.22%	Ming Ping Huang	2,800,000	HK$166.9m	0%	no data
1.22%	Yuanzhong Liu	2,800,000	HK$166.9m	0%	no data
1.2%	Prudence Investment Management (Hong Kong) Limited	2,757,440	HK$164.4m	0%	100.0%
1.09%	Hwabao WP Fund Management Co., Ltd	2,513,588	HK$149.9m	1.34%	0.14%
1.06%	GF Fund Management Co., Ltd.	2,442,349	HK$145.6m	0%	0.02%
1.05%	Wenbin Wang	2,407,348	HK$143.5m	0%	no data
1%	Morgan Stanley, Investment Banking and Brokerage Investments	2,293,225	HK$136.7m	0%	no data
1%	Weidong Tao	2,291,800	HK$136.6m	0%	no data
0.93%	The Vanguard Group, Inc.	2,146,446	HK$128.0m	0%	no data
0.91%	Fullgoal Fund Management Co. Ltd.	2,094,176	HK$124.9m	0%	0.02%
0.82%	Jiaxing Tongxin Asset Management Co., Ltd.	1,890,280	HK$112.7m	0%	no data
0.65%	Bosera Asset Management Co., Ltd.	1,493,247	HK$89.0m	0%	0.06%
0.34%	Penghua Fund Management Co., Ltd.	780,485	HK$46.5m	0%	0.03%
0.26%	Yiyi Chen	593,964	HK$35.4m	0%	no data
0.21%	Renbao Gan	486,500	HK$29.0m	0%	no data
0.2%	China Southern Asset Management Co., Ltd.	450,453	HK$26.9m	0%	no data
0.18%	Guotai Asset Management Company Limited	424,908	HK$25.3m	0%	0.01%
0.16%	Dimensional Fund Advisors LP	369,021	HK$22.0m	2.24%	no data
0.13%	China Asset Management Co. Ltd.	301,908	HK$18.0m	0%	no data
0.12%	E Fund Management Co., Ltd.	285,281	HK$17.0m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 05:03
End of Day Share Price	2024/12/24 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Haohai Biological Technology Co., Ltd. is covered by 17 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jingwei Qi	China Merchants Securities Co. Ltd.
Xiaofang Xu	Citic Securities Co., Ltd.
Eva Zhao	Citigroup Inc